Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks

2016 
NantKwest, Inc, Culver City, California, USA. ISCT Past Co-Chair, NA LRA Committee 2011–2014, St Jude Children’s Research Hospital, Memphis,Tennessee, USA. ISCT Past Co-Chair, NA LRA Committee 2011–2014. ISCT North America, RegionalVice-President 2014–2016, Department of Pathology, University of Melbourne, Cell Therapies Pty Ltd, East Melbourne,Australia, ISCT Australia & New Zealand, Past RegionalVice President 2012– 2014 and Chair, ISCT ANZ LRA Committee 2014–2016, Andalusian Initiative for Advanced Therapies, Junta de Andalucia, Sevilla, Spain. Chair, ISCT EU LRA Committee 2014–2016, and Moffitt Cancer Center and Research Institute,Tampa, Florida, USA. Chair, ISCT NA LRA Committee 2014–2016. Co-Editor of the Telegraft
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    10
    References
    7
    Citations
    NaN
    KQI
    []